TOMELLERI, Giuliano
 Distribuzione geografica
Continente #
NA - Nord America 6.941
EU - Europa 5.733
AS - Asia 4.036
SA - Sud America 567
Continente sconosciuto - Info sul continente non disponibili 99
AF - Africa 77
OC - Oceania 7
Totale 17.460
Nazione #
US - Stati Uniti d'America 6.836
RU - Federazione Russa 1.878
SG - Singapore 1.562
GB - Regno Unito 1.489
CN - Cina 1.321
BR - Brasile 482
IT - Italia 429
DE - Germania 369
SE - Svezia 360
HK - Hong Kong 351
FR - Francia 343
FI - Finlandia 329
VN - Vietnam 315
IE - Irlanda 239
KR - Corea 141
UA - Ucraina 129
BD - Bangladesh 73
TR - Turchia 57
CA - Canada 54
IN - India 51
NL - Olanda 36
BE - Belgio 33
MX - Messico 32
JP - Giappone 31
AR - Argentina 26
IQ - Iraq 21
ID - Indonesia 20
NG - Nigeria 19
PK - Pakistan 19
PL - Polonia 19
ES - Italia 18
ZA - Sudafrica 16
CL - Cile 14
CO - Colombia 12
AT - Austria 10
UZ - Uzbekistan 10
EC - Ecuador 9
MY - Malesia 8
PE - Perù 8
AZ - Azerbaigian 7
EG - Egitto 7
IL - Israele 7
AE - Emirati Arabi Uniti 6
AU - Australia 6
KE - Kenya 6
MA - Marocco 6
CZ - Repubblica Ceca 5
JO - Giordania 5
LT - Lituania 5
PY - Paraguay 5
UY - Uruguay 5
AL - Albania 4
CR - Costa Rica 4
HU - Ungheria 4
JM - Giamaica 4
NP - Nepal 4
PH - Filippine 4
PT - Portogallo 4
BO - Bolivia 3
CH - Svizzera 3
ET - Etiopia 3
HR - Croazia 3
IR - Iran 3
KG - Kirghizistan 3
LB - Libano 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
VE - Venezuela 3
AO - Angola 2
CG - Congo 2
DZ - Algeria 2
EE - Estonia 2
EU - Europa 2
GT - Guatemala 2
KZ - Kazakistan 2
LU - Lussemburgo 2
LV - Lettonia 2
MT - Malta 2
NI - Nicaragua 2
NO - Norvegia 2
OM - Oman 2
RO - Romania 2
RS - Serbia 2
SA - Arabia Saudita 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BB - Barbados 1
BG - Bulgaria 1
BJ - Benin 1
BN - Brunei Darussalam 1
CD - Congo 1
CI - Costa d'Avorio 1
CM - Camerun 1
DK - Danimarca 1
DM - Dominica 1
DO - Repubblica Dominicana 1
GA - Gabon 1
Totale 17.347
Città #
Southend 1.290
Jacksonville 843
Singapore 805
Dallas 749
Moscow 613
Ashburn 605
Chandler 605
San Jose 577
Woodbridge 559
Hong Kong 348
Ann Arbor 318
Dublin 238
Houston 233
Beijing 216
Verona 214
The Dalles 192
New York 157
Munich 124
Los Angeles 121
Lawrence 111
Princeton 111
Wilmington 111
Ho Chi Minh City 106
Jinan 105
Nanjing 99
Helsinki 94
Council Bluffs 93
Shenyang 87
Hanoi 74
Columbus 56
Santa Clara 55
Hebei 54
Buffalo 51
Tianjin 46
Sindelfingen 44
Dearborn 40
Milan 39
São Paulo 38
Changsha 37
Taiyuan 37
Taizhou 36
Nanchang 34
Guangzhou 33
Haikou 32
Hangzhou 32
Ningbo 32
Lancaster 30
Brussels 28
Zhengzhou 27
Tokyo 26
Boardman 25
Jiaxing 24
Redondo Beach 24
Seattle 24
Orem 22
Turku 22
Seoul 19
Amsterdam 18
Brooklyn 18
Chicago 18
Denver 18
Montreal 18
Norwalk 18
Warsaw 18
Abuja 17
Chennai 17
Fuzhou 17
Frankfurt am Main 16
London 16
Atlanta 15
Auburn Hills 15
Poplar 15
San Francisco 15
Toronto 15
Haiphong 14
Belo Horizonte 13
Da Nang 13
Lanzhou 13
Rio de Janeiro 13
Riva 13
Johannesburg 12
Phoenix 12
Falls Church 11
Washington 11
Boston 10
Clearwater 10
Fairfield 10
Jakarta 10
Kent 10
Manchester 10
Tashkent 10
Baghdad 9
Mumbai 9
Nuremberg 9
Rome 9
Biên Hòa 8
Catania 8
Istanbul 8
Redmond 8
Stockholm 8
Totale 11.320
Nome #
A mutation in the CASQ1 gene causes a vacuolar myopathy with accumulation of sarcoplasmic reticulum protein aggregates. 325
Abnormal expression of RNA polymerase II associated proteins in muscle of patients with myofibrillar myopathies. 271
Overexpression of TNF-α in mitochondrial diseases caused by mutations in mtDNA: evidence for signaling through its receptors on mitochondria. 251
AZT-induced mitochondrial myopathy 238
Antisulfatide polyneuropathy: antibody-mediated complement attack on peripheral myelin 237
Bortezomib-induced muscle toxicity in multiple myeloma 232
Anatomical and clinical study of a case of subacute encephalomyelitis with hyperekplexia syndrome. 227
Course and management of allogeneic stem cell transplantation in patients with mitochondrial neurogastrointestinal encephalomyopathy. 226
Increased protein nitration in mitochondrial diseases: evidence for vessel wall involvement. 225
Botulinum toxin treatment of muscle cramps: a clinical and neurophysiological study 225
The role of brain MRI in mitochondrial neurogastrointestinal encephalomyopathy. 222
Antioxidant agents have a different expression pattern in muscle fibers of patients with mitochondrial diseases 220
Autophagy, inflammation and innate immunity in inflammatory myopathies. 219
[Myopathy with lipid accumulation and type-II glutaric aciduria] 218
Axillary injection of botulinum. A toxin in a patient with muscle craps associated with severe axillary hyperhydrosis 216
Acute reversible paralysis in critically ill patients 215
Oral zinc sulphate treatment in Wilson's disease 200
Mitochondrial sensorineural hearing loss: a retrospective study and a description of cochlear implantation in a MELAS patient. 200
Endothelial dysfunction and increased oxidative stress in mitochondrial diseases. 199
Hypokalemic periodic paralysis: a single fiber electromyographic study 193
Adult-onset muscular dystrophy in a cat associated with a presumptive alteration in trafficking of caveolin-3. 192
Evidence for caspase-dependent programmed cell death along with repair processes in affected skeletal muscle fibres in patients with mitochondrial disorders 192
A new mutation in the mitochondrial tRNA(Ala) gene in a patient with ophthalmoplegia and dysphagia 190
McArdle disease and sporadic inclusion-body myositis. 190
Brody Disease: insights into biochemical features of SERCA1 and identification of a novel mutation. 186
Selective pseudohypertrophy of vastus medialis muscles associated with calpain 3 deficiency. 186
Aspetti elettromiografici e istologici in corso di Malattia di Friedreich[Electromyographic and histological aspects during a course of Friedreich's disease] 184
Acute sarcomeric M-Line Disease associated with ATP synthase subunit α autoantibodies in ankylosing spondylitis 184
Il granuloma polmonare lipoideo nel morbo di Parkinson [Lipoid pulmonary granuloma in Parkinson's disease. Presentation of clinical case] 179
Clinical, morphological and genetic studies in a cohort of 21 patients with myofibrillar myopathy. 179
Two and half years of oral zinc sulphate therapy in an adult patient with Wilson's disease. 178
Calpain 3 deficiency presenting as fiber type disproportion. 176
Endothelial dysfunction in mitochondrial diseases: biological and biochemical evidence of increased oxidative stress and peroxinitrite generation 174
Anti-acetylcoline receptor antibodies, thymic histology and clinical parameters in myastenia gravis. 173
Characterization of sarcoplasmic reticulum Ca(2+) ATPase pumps in muscle of patients with myotonic dystrophy and with hypothyroid myopathy 173
A standardized clinical evaluation of patients affected by facioscapulohumeral muscular dystrophy: The FSHD clinical score. 172
Non-hematologic toxicity of bortezomib in multiple myeloma: the neuromuscular and cardiovascular adverse effects 172
Immunoblot as a potential diagnostic tool for myofibrillar myopathies 170
Polymyositis in solid organ transplant recipients receiving tacrolimus. 168
Polimiosite infantile: descrizione di un caso [Infantile polymyositis: a case description] 167
Facioscapulohumeral muscular dystrophy: a multicenter study on hearing function 167
T-cell anti-apoptotic mechanisms in inflammatory myopathies 166
Increased expression of the normal cellular isoform of prion protein in inclusion-body myositis, inflammatory myopathies and denervation atrophy 165
Evidence of ER stress and UPR activation in patients with Brody disease and Brody syndrome 164
Chronic ophthalmoparesis in limb girdle muscular dystrophy 1C. 164
Cutis verticis gyrata, mental retardation and Lennox-Gastaut syndrome: a case report 163
SERCA1 protein expression in muscle of patients with Brody disease and Brody syndrome and in cultured human muscle fibers. 163
Pitfalls in diagnosing mitochondrial neurogastrointestinal encephalomyopathy. 162
Programmed cell death occurs in muscle fibers with mitochondrial dysfunction 161
The role of muscle biopsy in investigating isolated muscle pain 161
Human skeletal muscle as a target organ of trichloroethylene toxicity. 159
Systemic sclerosis and superficial siderosis of the central nervous system: casuality or causality? 158
Current options in the treatment of mitochondrial diseases. 157
An Italian multicentre randomized study on early treatment of Parkinson disease: Comparison of L-dopa, L-deprenyl and dopamine-agonists. Study design and preliminary results. 156
(CTG)n triplet mutation and phenotype manifestations in myotonic dystrophy patients 155
Central-peripheral sensory axonopathy in a juvenile case of Alpers-Huttenlocher disease 153
Transcription factors c-Jun/activator protein-1 and nuclear factor-kappa B in oxidative stress response in mithocondrial diseases 152
Whole-exome sequencing in patients with protein aggregate myopathies reveals causative mutations associated with novel atypical phenotypes 151
Critical illness myopathy and neuropathy 150
A case of persistent thyrotoxic myopathy 150
SERCA1 and calsequestrin storage myopathy: a new surplus protein myopathy. 149
Expression of Protein Kinase C isoforms and interleukin-1beta in myofibrillar myopathy 149
Sarcoidosis and inclusion body myositis. 147
Natural history of motor neuron disease in adult onset GM2-gangliosidosis: a case report with 25 years of follow-up 146
Congenital muscular dystrophy and cerebellar vermis agenesis in two brothers 145
Miopatia distale sporadica: descrizione di un caso in un soggetto femminile [Sporadic distal myopathy. Description of a case in a patient of the female sex] 144
Duplication of dystrophin gene and dissimilar clinical phenotype in the same family 142
Malattia del motoneurone 141
Cationic PMMA nanoparticles bind and deliver antisense oligoribonucleotides allowing restoration of dystrophin expression in the mdx mouse. 140
Neuropatie familiari con tendenza alla paralisi da compressione. Correlazioni cliniche, neurofisiologiche ed istopatologiche 139
Involvement of the peripheral nervous system in spino-cerebellar ataxia (neurophysiological and histopathological findings) 138
Relapsing-remitting painful masses of the skeletal muscle 138
Protein expression of canine and feline muscular dystrophies 138
Neuropathology of mitochondrial diseases 138
Reversible upper limb muscle weakness with selective loss of thick filaments 137
The role of mitochondria in neurodegenerative diseases. 131
Expression of late myogenic differentiation markers in sarcoplasmic masses of patients with myotonic dystrophy 129
Critically ill patients: immunological evidence of inflammation in muscle biopsy 128
Phenytoin-phenobarbiatl interaction: importance of free plasma phenytoin monitoring 127
Distrofia muscolare oculo-faringea. Descrizione di un caso con interessamento del Sistema Nervoso Centrale [Oculopharyngeal muscular dystrophy. Description of a case with involvement of the central nervous system] 124
Miotoniche, sindromi 124
Riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency: delayed hypersensitivity reaction and efficacy of low-dose intermittent supplementation 122
Identification and characterization of three novel mutations in the CASQ1 gene in four patients with tubular aggregate myopathy 122
Increased serum levels of ICAM-1 ELAM-1 and TNF-a in inflammatory disorders of peripheral nervous system 120
Unusual presentation of phosphoglycerate mutase deficiency due to two different mutations in PGAM-M gene. 120
Hyperpyrexia-triggered relapses in an unusual case of ataxic chronic inflammatory demyelinating polyradiculoneuropathy. 117
Features of cell death in brain and liver, the target tissues of progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher disease) 117
Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosis 117
Motor neuron disease and HIV-infection in 30-years-old HIV positive heroin abuser: a causal relationship? 116
Facioscapulohumeral muscular dystrophy: epidemiological and molecular study in a north-east Italian population sample. 116
Myopathy in long-term AZT therapy: clinical, electrophysiological and biopsy study in 67 HIV+ subjects 114
Facioscapulohumeral muscular dystrophy: hearing loss and other atypical features of patients with large 4q35 deletions. 113
Progression of carotid atheromatous involvement in cerebrovascular patients. 113
Sporadic adult onset distal myopathy 112
Phenotype modulators in myophosphorylase deficiency 112
Eyelid ptosis from sympathetic nerve dysfunction mistaken as myopathy: a simple test to identify this condition 112
Chronic alcoholic and corticosteroid myopathy 111
Dermatomyositis and retroperitoneal germ cell cancer 111
Minipolymyoclonus in congenital nemaline myopathy: a nonspecific clinical marker of neurogenic dysfunction 111
Paraplegia spastica familiare 109
Totale 16.400
Categoria #
all - tutte 58.143
article - articoli 54.281
book - libri 0
conference - conferenze 2.103
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.759
Totale 116.286


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022915 0 399 4 98 17 18 15 46 29 20 78 191
2022/20231.784 151 164 173 294 175 379 23 117 230 6 43 29
2023/2024746 41 56 65 90 85 142 19 63 9 36 90 50
2024/20252.356 126 135 59 344 133 100 175 135 360 128 197 464
2025/20266.625 446 643 482 988 1.622 419 581 263 559 336 135 151
2026/202765 52 13 0 0 0 0 0 0 0 0 0 0
Totale 17.460